Evaluation of solid lipid nanoparticles containing Isotretinoin in treatment of acne

Phase 2

• Conditions: Acne Vulgaris.; Acne

• Registration Number: IRCT201203283862N9
• Lead Sponsor: ano Technology Research Center,Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Acne vulgaris patients with grade 2 and 3 base on Investigator Global Assessment; No receiving topical treatment of acne from 4 weeks before this regimen.
exclusion criteria:Androgenic acne;Acne due to drugs or cosmetics; Adrenal or Hormonal disorders.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Inflammatory and non-inflamatory lesions. Timepoint: Biweekly after starting treatment. Method of measurement: Observation and calculating of elementary lesions based on photographic image.

Secondary Outcome Measures

Name	Time	Method
Evaluation of side effects like skin irritation , erythema , skin dryness.pruritus. Timepoint: Biweekly. Method of measurement: Observation and severity scoring from + to +++.